| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |